Advertisement

Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance

      Abstract

      Background

      Prostate-specific antigen (PSA), a biomarker for semen exposure, may provide a more objective measure of condom failure than subject self-reports. Methods for measuring PSA vary and their comparability with respect to assessing condom performance has not been adequately evaluated. This study compared results from three different PSA assays of vaginal samples collected by subjects in a randomized clinical trial which compared the performance of female condoms.

      Study Design

      We selected 30 pairs of pre- and post-coital vaginal samples from subjects who reported condom functionality problems or whose original PSA assay was positive. Samples were retested using three different PSA assays [quantitative enzyme-linked immunoassay (EIA), rocket immune-electrophoresis (RIE) and chromatographic immunoassay (CIA)]. We compared the proportion of condom uses where the post-coital PSA result indicated semen exposure for each of the three assays.

      Results

      Despite varying levels of sensitivity, the results from all three assays were remarkably consistent. Self-reported condom failures did not correlate well with positive PSA results, suggesting that exclusive reliance on either PSA or user self-report may be inadequate for assessing condom functionality.

      Conclusion

      In combination with user self-report of condom failure, PSA testing provides a reliable, objective marker of condom functionality. Studies based on PSA testing may improve on conventional contraceptive clinical trials by offering a more direct assessment of a condom product's ability to prevent semen exposure.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mauck C.K.
        • Doncel G.F.
        • Biomarkers of Semen Exposure Clinical Working Group
        Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.
        Contraception. 2007; 75 ([Epub 2007 Apr 30]): 407-419
        • Lawson M.L.
        • Macaluso M.
        • Bloom A.
        • Hortin G.
        • Hammond K.R.
        • Blackwell R.
        Objective markers of condom failure.
        Sex Transm Dis. 1998; 25: 427-432
        • Macaluso M.
        • Lawson L.
        • Akers R.
        • et al.
        Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.
        Contraception. 1999; 59: 195-201
        • Walsh T.L.
        • Frezieres R.G.
        • Nelson A.L.
        • Wraxall B.G.
        • Clark V.A.
        Evaluation of prostate-specific antigen as a quantifiable indicator of condom failure in clinical trials.
        Contraception. 1999; 60: 289-298
        • Lawson M.L.
        • Macaluso M.
        • Duerr A.
        • et al.
        Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom.
        Am J Epidemiol. 2003; 157: 282-288
        • Macaluso M.
        • Lawson M.L.
        • Hortin G.
        • Duerr A.
        • Hammond K.R.
        • Blackwell R.
        • et al.
        Efficacy of the female condom as a barrier to semen during intercourse..
        Am J Epidemiol. 2003; 157: 289-297
        • Walsh T.L.
        • Frezieres R.G.
        • Peacock K.
        • et al.
        Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted disease.
        Contraception. 2003; 67: 139-150
        • Walsh T.L.
        • Frezieres R.G.
        • Peacock K.
        • et al.
        Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials.
        Contraception. 2004; 70: 407-413
        • Galvao L.W.
        • Oliveira L.C.
        • Jua D.
        • et al.
        Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial.
        Contraception. 2005; 71: 130-136
        • Macaluso M.
        • Blackwell R.
        • Jamieson D.J.
        • et al.
        Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial.
        Am J Epidemiol. 2007; 166: 88-96
        • Chen M.P.
        • Macaluso M.
        • Blackwell R.
        • et al.
        Self-reported mechanical problems during condom use and semen exposure. Comparison of two randomized trials in the United States of America and Brazil.
        Sex Transm Dis. 2007; 34: 557-562
        • Bahamondes L.
        • Diaz J.
        • Marchi N.M.
        • et al.
        Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: comparison of self-collected and nurse-collected samples.
        Hum Reprod. 2008; 23: 2444-2451
        • Gallo M.F.
        • Behets F.M.
        • Steiner M.J.
        • et al.
        Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen.
        Sex Transm Dis. 2006; 33: 476-479
        • Gallo M.F.
        • Behets F.M.
        • Steiner M.J.
        • et al.
        Validity of self-reported ���safe sex��� among female sex workers in Mombasa, Kenya���PSA analysis.
        Int J STD AIDS. 2007; 18: 33-38
        • Gallo M.F.
        • Steiner M.J.
        • Hobbs M.M.
        • et al.
        Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data.
        AIDS Behav. 2010; 14: 1279-1286
        • Minnis A.M.
        • Steiner M.J.
        • Gallo M.F.
        • et al.
        Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe.
        Am J Epidemiol. 2009; 170 ([Epub 2009 Sep 9]): 918-924
        • Miller D.C.
        • Hollenbeck B.K.
        • Smith G.D.
        • et al.
        Processed total motile sperm count correlates with pregnancy outcome after intrauterine insemination.
        Urology. 2002; 60: 497-501
        • Irvine D.S.
        Epidemiology and aetiology of male infertility.
        Hum Reprod. 1998; 13: 33-44
        • J��rgensen N.
        • Auger J.
        • Giwercman A.
        • et al.
        Semen analysis performed by different laboratory teams: an intervariation study.
        Int J Androl. 1997; 20: 201-208